COLD LAKE – The City of Cold Lake will be backing a major research project connected to its transit system.

Replimune received an FDA denial for accelerated approval of RP1+Opdivo in melanoma, with trial concerns outweighing strong data. Read why REPL stock is a hold.

The annual funding is provided as a one-time payment to energy suppliers, who then apply a £150 credit to the accounts of eligible UK residents ...

If you're chasing a $50,000 credit limit, these three cards might be your best shot. Big perks, big welcome offers, and ...

ProSocial AI can serve to ensure that AI serves natural intelligence, as a force for collective flourishing. Here is a peek on what this means ...

The one-off annual funding is issued to energy suppliers, they then credit the £150 to the accounts of UK residents who ...

The one-off annual funding is issued to energy suppliers, they then credit the £150 to the accounts of UK residents who qualify for it ...

After losing her job offer post-graduation, a Gen Zer shares how she landed a new role nine months later, protecting her visa ...

A judge has risen to consider whether "decisive" evidence in the prosecution of a former paratrooper for two murders in ...

Valby, Denmark, 20 September 2025 - H. Lundbeck A/S (Lundbeck) and Otsuka America Pharmaceutical, Inc., (Otsuka) announce that Otsuka has received a Complete Response Letter (CRL) from the U.S. Food a ...

The Australian Taxation Office is ramping up its pursuit of Jon Adgemis, asking a court to allow it to take the place of ...

After claims circulated online alleging the City of Morristown wrongly denied an application for a prayer vigil at the ...